The relationship between nasopharyngeal CCL5 and microbiota on disease severity among infants with bronchiolitis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 72, Issue 11, 2017, Pages 1796-1800

  Hasegawa, K ^a   Mansbach, J M ^b   Ajami, N J ^c   Petrosino, J F ^c   Freishtat, R J ^d   Teach, S J ^d   Piedra, P A ^c   Camargo, C A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

airway; bronchiolitis; CCL5 RANTES; microbiota; severity

Indexed keywords

RANTES; CCL5 PROTEIN, HUMAN;

ARTICLE; BRONCHIOLITIS; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; HAEMOPHILUS; HIGH RISK PATIENT; HOSPITALIZED INFANT; HUMAN; INFANT; INFANT DISEASE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORAXELLA; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; STREPTOCOCCUS; CHEMISTRY; CLINICAL TRIAL; INTENSIVE CARE UNIT; MICROBIOLOGY; MICROFLORA; NASOPHARYNX; NEWBORN; PATHOLOGY;

BRONCHIOLITIS; CHEMOKINE CCL5; HAEMOPHILUS; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS; LENGTH OF STAY; MICROBIOTA; MORAXELLA; NASOPHARYNX;

EID: 85017420969     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.13160     Document Type: Article

References (12)

1. Hasegawa K, Tsugawa Y, Brown DF, Mansbach JM, Camargo CA Jr. Trends in bronchiolitis hospitalizations in the United States, 2000-2009. Pediatrics. 2013;132:28-36.
2. de Steenhuijsen Piters WA, Heinonen S, Hasrat R, et al. Nasopharyngeal microbiota, host transcriptome and disease severity in children with respiratory syncytial virus infection. Am J Respir Crit Care Med. 2016;194:1104-1115.
3. Mansbach JM, Hasegawa K, Henke DM, et al. Respiratory syncytial virus and rhinovirus severe bronchiolitis are associated with distinct nasopharyngeal microbiota. J Allergy Clin Immunol. 2016;137:1909-1913.
4. Hasegawa K, Mansbach JM, Ajami NJ, et al. Association of nasopharyngeal microbiota profiles with bronchiolitis severity in infants hospitalized for bronchiolitis. Eur Respir J. 2016;48:1329-1339.
5. Hasegawa K, Mansbach JM, Ajami NJ, et al. Serum cathelicidin, nasopharyngeal microbiota, and disease severity in infants hospitalized with bronchiolitis. J Allergy Clin Immunol. 2017;139:1383-1386.
6. Bacharier LB, Cohen R, Schweiger T, et al. Determinants of asthma after severe respiratory syncytial virus bronchiolitis. J Allergy Clin Immunol. 2012;130:91-100.
7. Berube J, Bourdon C, Yao Y, Rousseau S. Distinct intracellular signaling pathways control the synthesis of IL-8 and RANTES in TLR1/TLR2, TLR3 or NOD1 activated human airway epithelial cells. Cell Signal. 2009;21:448-456.
8. Elinav E, Strowig T, Kau AL, et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell. 2011;145:745-757.
9. Hu B, Elinav E, Huber S, et al. Microbiota-induced activation of epithelial IL-6 signaling links inflammasome-driven inflammation with transmissible cancer. Proc Natl Acad Sci U S A. 2013;110:9862-9867.
10. Ralston SL, Lieberthal AS, Meissner HC, et al. Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. Pediatrics. 2014;134:e1474-1502.
11. McDougall CM, Blaylock MG, Douglas JG, Brooker RJ, Helms PJ, Walsh GM. Nasal epithelial cells as surrogates for bronchial epithelial cells in airway inflammation studies. Am J Respir Cell Mol Biol. 2008;39:560-568.
12. Marsh RL, Kaestli M, Chang AB, et al. The microbiota in bronchoalveolar lavage from young children with chronic lung disease includes taxa present in both the oropharynx and nasopharynx. Microbiome. 2016;4:37.